Publications
By Year
Now showing items 121-140 of 4875 records
Effects of Lifestyle Interventions on Cardiovascular Disease Risk and Risk Factors Among Individuals at High Risk for Type 2 Diabetes: Protocol for a Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Getu Debalkie Demissie; Josephine Birungi; Tilahun Haregu; Sathish Thirunavukkarasu; Brian Oldenburg
27 Jun 2024
Individuals at high risk for type 2 diabetes are also at an increased risk for developing cardiovascular disease (CVD). Although there are separate trials examining the effects of lifestyle interventions on absolute CVD risk among people at high risk for type 2 diabetes, a comprehensive evidence synthesis of these trials is lacking. We will systematically synthesize the evidence on the effects ...
Depletion of follicular B cell-derived antibody secreting cells does not attenuate angiotensin II-induced hypertension or vascular compliance.
Hericka Bruna Figueiredo Galvao; Maggie Lieu; Seyuri Moodley; Henry Diep; Maria Jelinic; Alexander Bobik; Christopher G Sobey; Grant R Drummond; Antony Vinh
FRONTIERS IN CARDIOVASCULAR MEDICINE - 01 Jan 2024
Marginal zone and follicular B cells are known to contribute to the development of angiotensin II-induced hypertension in mice, but the effector function(s) mediating this effect (e.g., antigen presentation, antibody secretion and/or cytokine production) are unknown. B cell differentiation into antibody secreting cells (ASCs) requires the transcription factor Blimp-1. Here, we studied mice with...
Dietary resistant starch enhances immune health of the kidney in diabetes via promoting microbially-derived metabolites and dampening neutrophil recruitment.
Matthew Snelson; Devy Deliyanti; Sih Min Tan; Anna M Drake; Cassandra de Pasquale; Vinod Kumar; Trent M Woodruff; Jennifer L Wilkinson-Berka; Melinda T Coughlan
NUTRITION & DIABETES - 20 Jun 2024
Dietary-resistant starch is emerging as a potential therapeutic tool to limit the negative effects of diabetes on the kidneys. However, its metabolic and immunomodulatory effects have not yet been fully elucidated. Six-week-old db/db mice were fed a diet containing 12.5% resistant starch or a control diet matched for equivalent regular starch for 10 weeks. db/m mice receiving the control diet w...
A lipidomic based metabolic age score captures cardiometabolic risk independent of chronological age.
Tingting Wang; Habtamu B Beyene; Changyu Yi; Michelle Cinel; Natalie A Mellett; Gavriel Olshansky; Thomas G Meikle; Jingqin Wu; Aleksandar Dakic; Gerald F Watts; Joseph Hung; Jennie Hui; John Beilby; John Blangero; Rima Kaddurah-Daouk; Agus Salim; Eric K Moses; Jonathan E Shaw; Dianna J Magliano; Kevin Huynh; Corey Giles; Peter J Meikle
EBIOMEDICINE - 20 Jun 2024
Metabolic ageing biomarkers may capture the age-related shifts in metabolism, offering a precise representation of an individual's overall metabolic health. Utilising comprehensive lipidomic datasets from two large independent population cohorts in Australia (n = 14,833, including 6630 males, 8203 females), we employed different machine learning models, to predict age, and calculated metabolic ...
Evaluation of polygenic scoring methods in five biobanks shows larger variation between biobanks than methods and finds benefits of ensemble learning.
Remo Monti; Lisa Eick; Georgi Hudjashov; Kristi Läll; Stavroula Kanoni; Brooke N Wolford; Benjamin Wingfield; Oliver Pain; Sophie Wharrie; Bradley Jermy; Aoife McMahon; Tuomo Hartonen; Henrike Heyne; Nina Mars; Samuel Lambert; ; Kristian Hveem; Michael Inouye; David A van Heel; Reedik Mägi; Pekka Marttinen; Samuli Ripatti; Andrea Ganna; Christoph Lippert
AMERICAN JOURNAL OF HUMAN GENETICS - 20 Jun 2024
Methods of estimating polygenic scores (PGSs) from genome-wide association studies are increasingly utilized. However, independent method evaluation is lacking, and method comparisons are often limited. Here, we evaluate polygenic scores derived via seven methods in five biobank studies (totaling about 1.2 million participants) across 16 diseases and quantitative traits, building on a reference...
The Discovery of Extracellular Vesicles and Their Emergence as a Next-Generation Therapy.
Alin Rai; Bethany Claridge; Jonathan Lozano; David W Greening
CIRCULATION RESEARCH - 21 Jun 2024
From their humble discovery as cellular debris to cementing their natural capacity to transfer functional molecules between cells, the long-winded journey of extracellular vesicles (EVs) now stands at the precipice as a next-generation cell-free therapeutic tool to revolutionize modern-day medicine. This perspective provides a snapshot of the discovery of EVs to their emergence as a vibrant fie...
The role of activator protein-1 (AP-1) complex in diabetes associated atherosclerosis: Insights from single cell RNA sequencing.
Abdul Waheed Khan; Misbah Aziz; Karly C Sourris; Man Ks Lee; Aozhi Dai; Anna Md Watson; Scott Maxwell; Arpeeta Sharma; Ying Zhou; Mark E Cooper; Anna C Calkin; Andrew J Murphy; Sara Baratchi; Karin Am Jandeleit-Dahm
DIABETES - 21 Jun 2024
Despite advances in the treatment of atherosclerotic cardiovascular disease, it remains the leading cause of death in patients with diabetes. Even when risk factors are mitigated, the disease progresses, and thus newer targets need to be identified that directly inhibit the underlying pathobiology of atherosclerosis in diabetes. A single cell sequencing approach was utilised to distinguish the ...
The Final Frontier in Diabetes Care: Implementing Research in Real-World Practice.
Jennifer B Green; Matthew J Crowley; Sathish Thirunavukkarasu; Nisa M Maruthur; Brian Oldenburg
DIABETES CARE - 22 Jun 2024
Despite extensive evidence related to the prevention and management of type 2 diabetes (T2D) and its complications, most people at risk for and people who have diabetes do not receive recommended guideline-based care. Clinical implementation of proven care strategies is of the utmost importance because without this, even the most impressive research findings will remain of purely academic inter...
Platelet-targeted thromboprophylaxis with a human serum albumin fusion drug: Preventing thrombosis and reducing cardiac ischemia/reperfusion injurywithout bleeding complications.
Yuyang Song; Laura A Bienvenu; Viktoria Bongcaron; Shania A Prijaya; Ana C Maluenda; Aidan P G Walsh; James D McFayden; Geoffrey A Pietersz; Karlheinz Peter; Xiaowei Wang
THERANOSTICS - 01 Jan 2024
<b>Background:</b> Myocardial infarction (MI) as a consequence of atherosclerosis-associated acute thrombosis is a leading cause of death and disability globally. Antiplatelet and anticoagulant drugs are standard therapies in preventing and treating MI. However, all clinically used drugs are associated with bleeding complications, which ultimately limits their use in patients with a high risk o...
Aberrancy masquerading as ventricular tachycardia: Importance of invasive electrophysiology study for diagnosis of wide complex tachycardias.
Jeremy William; Peter M Kistler Mbbd; Jonathan M Kalman; Melvin Scheinman; Hariharan Sugumar; Sandeep Prabhu; Liang-Han Ling; Vasath Vedantham; Zian Tseng; Joshua Moss; Edward P Gerstenfeld; Aleksandr Voskoboinik
JOURNAL OF ELECTROCARDIOLOGY - 08 Jun 2024
Differentiation between ventricular tachycardia (VT) and supraventricular tachycardia (SVT) with aberrancy based on the 12‑lead ECG alone can be imprecise. Implantable cardiac defibrillators (ICD) may be inserted for presumed VT, particularly in patients with syncopal presentation or atypical aberrancy patterns. Accurate diagnosis of these patients facilitated by an electrophysiology study (EPS...
Role of aptamer technology in extracellular vesicle biology and therapeutic applications.
Rocky Chowdhury; Sadegh Eslami; Cuong Viet Pham; Alin Rai; Jia Lin; Yingchu Hou; David W Greening; Wei Duan
NANOSCALE - 10 Jun 2024
Extracellular vesicles (EVs) are cell-derived nanosized membrane-bound vesicles that are important intercellular signalling regulators in local cell-to-cell and distant cell-to-tissue communication. Their inherent capacity to transverse cell membranes and transfer complex bioactive cargo reflective of their cell source, as well as their ability to be modified through various engineering and mod...
Development and validation of a plasmalogen score as an independent modifiable marker of metabolic health: population based observational studies and a placebo-controlled cross-over study.
Habtamu B Beyene; Kevin Huynh; Tingting Wang; Sudip Paul; Michelle Cinel; Natalie A Mellett; Gavriel Olshansky; Thomas G Meikle; Gerald F Watts; Joseph Hung; Jennie Hui; John Beilby; John Blangero; Eric K Moses; Jonathan E Shaw; Dianna J Magliano; Corey Giles; Peter J Meikle
EBIOMEDICINE - 10 Jun 2024
Decreased levels of circulating ethanolamine plasmalogens [PE(P)], and a concurrent increase in phosphatidylethanolamine (PE) are consistently reported in various cardiometabolic conditions. Here we devised, a plasmalogen score (Pls Score) that mirrors a metabolic signal that encompasses the levels of PE(P) and PE and captures the natural variation in circulating plasmalogens and perturbations ...
Pediatric Blood Pressure and Cardiovascular Health in Adulthood.
Yaxing Meng; Jonathan P Mynard; Kylie J Smith; Markus Juonala; Elaine M Urbina; Teemu Niiranen; Stephen R Daniels; Bo Xi; Costan G Magnussen
CURRENT HYPERTENSION REPORTS - 15 Jun 2024
This review summarizes current knowledge on blood pressure in children and adolescents (youth), with a focus on primary hypertension-the most common form of elevated blood pressure in this demographic. We examine its etiology, progression, and long-term cardiovascular implications. The review covers definitions and recommendations of blood pressure classifications, recent developments in measur...
The worldwide trend in diabetes awareness, treatment, and control from 1985 to 2022: a systematic review and meta-analysis of 233 population-representative studies.
Ehsan Shahrestanaki; Nami Mohammadian Khonsari; Ehsan Seif; Fereshteh Baygi; Hanieh-Sadat Ejtahed; Ali Sheidaei; Shirin Djalalinia; Dianna J Magliano; Mostafa Qorbani
FRONTIERS IN PUBLIC HEALTH - 01 Jan 2024
With the rapid increase in the prevalence of DM, studies on the awareness, treatment, and control of this condition are essential. Therefore, this study aimed to review the literature and pool the awareness, treatment, and control of diabetes at the global, regional, and national levels. In this systematic review and meta-analysis, several databases, including MEDLINE/PubMed, Institute of Scien...
Genome-wide association studies and Mendelian randomization analyses provide insights into the causes of early-onset colorectal cancer.
R S Laskar; C Qu; J R Huyghe; T Harrison; R B Hayes; Y Cao; P T Campbell; R Steinfelder; F R Talukdar; H Brenner; S Ogino; S Brendt; D T Bishop; D D Buchanan; A T Chan; M Cotterchio; S B Gruber; A Gsur; B van Guelpen; M A Jenkins; T O Keku; B M Lynch; L Le Marchand; R M Martin; K McCarthy; V Moreno; R Pearlman; M Song; K K Tsilidis; P Vodička; M O Woods; K Wu; L Hsu; M J Gunter; U Peters; N Murphy;
ANNALS OF ONCOLOGY : OFFICIAL JOURNAL OF THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY - 01 Jun 2024
The incidence of early-onset colorectal cancer (EOCRC; diagnosed <50 years of age) is rising globally; however, the causes underlying this trend are largely unknown. CRC has strong genetic and environmental determinants, yet common genetic variants and causal modifiable risk factors underlying EOCRC are unknown. We conducted the first EOCRC-specific genome-wide association study (GWAS) and Mend...
Health economic analysis of polygenic risk score use in primary prevention of coronary artery disease - A system dynamics model.
Stephen T Vernon; Stuart Brentnall; Danielle J Currie; Cindy Peng; Michael P Gray; Giordano Botta; Deo Mujwara; Stephen J Nicholls; Stuart M Grieve; Julie Redfern; Clara Chow; Jean-Frederic Levesque; Peter J Meikle; Garry Jennings; Zanfina Ademi; Andrew Wilson; Gemma A Figtree
AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY - 01 Jun 2024
Primary prevention programs utilising traditional risk scores fail to identify all individuals who suffer acute cardiovascular events. We aimed to model the impact and cost effectiveness of incorporating a Polygenic risk scores (PRS) into the cardiovascular disease CVD primary prevention program in Australia, using a whole-of-system model. System dynamics models, encompassing acute and chronic ...
The impact of lifestyle factors on atrial fibrillation.
Michael W Lim; Jonathan M Kalman
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY - 03 Jun 2024
Atrial fibrillation (AF), with its significant associated morbidity and mortality contributes to significant healthcare utilisation and expenditure. Given its progressively rising incidence, strategies to limit AF development and progression are urgently needed. Lifestyle modification is a potentially potent but underutilised weapon against the AF epidemic. The purpose of this article is to rev...
The effects of electrical stimulation of ventromedial prefrontal cortex on skin sympathetic nerve activity.
Mariya Patel; Joe A Braun; Luke A Henderson; Tye Dawood; Vaughan G Macefield
CEREBRAL CORTEX (NEW YORK, N.Y. : 1991) - 04 Jun 2024
Skin sympathetic nerve activity (SSNA) is primarily involved in thermoregulation and emotional expression; however, the brain regions involved in the generation of SSNA are not completely understood. In recent years, our laboratory has shown that blood-oxygen-level-dependent signal intensity in the ventromedial prefrontal cortex (vmPFC) and dorsolateral prefrontal cortex (dlPFC) are positively ...
Prevalence and outcomes of patients with SMuRF-less acute coronary syndrome undergoing percutaneous coronary intervention.
Jocasta Ball; Diem T Dinh; Angela Brennan; Andrew Ajani; David J Clark; Melanie Freeman; Ernesto Oqueli; Chin Hiew; Shane Nanayakkara; Antony Walton; James A Shaw; William Chan; Christopher M Reid; Dion Stub
OPEN HEART - 05 Jun 2024
There is increasing awareness that patients without standard modifiable risk factors (SMuRFs; diabetes, hypercholesterolaemia, hypertension and smoking) may represent a unique subset of patients with acute coronary syndrome (ACS). We aimed to investigate the prevalence and outcomes of patients with SMuRF-less ACS undergoing percutaneous coronary intervention (PCI) compared with those with SMuRF...
Show more...